Quantcast

Latest Donepezil Stories

2014-07-15 04:22:13

Study Results Presented at the Alzheimer's Association International Conference 2014 INDIANAPOLIS, July 15, 2014 /PRNewswire/ -- Today, Eli Lilly and Company (NYSE:LLY) announced results from an analyses of five datasets evaluating the relationship between cognitive and functional impairment in patients with mild Alzheimer's disease in the natural course of the disease. Analysis findings demonstrate that cognitive deficits predict subsequent functional deficits and suggest that...

2014-07-07 16:24:29

THE WOODLANDS, Texas, July 7, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lonnel Coats has been appointed president and chief executive officer effective July 7, 2014. Mr. Coats most recently served as president and chief executive officer of Eisai Inc., the United States subsidiary of Eisai Co., Ltd. Mr. Coats joins Lexicon after 18 years of senior management experience with Eisai. As president and chief executive officer at Eisai, he...

2014-07-02 23:03:21

MarketReportsOnline.com adds "Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis" report to its research store. Dallas, Texas (PRWEB) July 02, 2014 Alzheimer’s is a complex disease and there is no single “magic bullet” available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimer’s disease, it still remains a significant area of unmet medical need. Clinical success has...

2014-07-01 16:27:12

LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Alzheimer%s Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_alzheimer_s_drugs_market_2012_2016.html About Alzheimer's DiseaseAlzheimer's disease is a progressive, irreversible degeneration of the brain that disrupts the thinking, language, behavioral and cognitive skills of a person. AD is more prevalent in people aged 65 years or above and...

2014-05-23 08:24:08

BOSTON, Mass., May 23, 2014 /PRNewswire/ -- AZTherapies, Inc. a company developing novel treatments for Alzheimer's disease based on technology licensed from Massachusetts General Hospital, announced that it has received notice from FDA that it may proceed with the Phase III clinical study submitted in its IND application. This study is for its lead program, ALZT-OP1, a novel combination therapy for the prevention and treatment of early Alzheimer's disease. ALZT-OP1 is a...

2014-04-30 12:30:34

Data Highlight Physician and Payer Expectations for New Symptomatic and Disease-Modifying Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., April 30, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. neurologists are particularly receptive to novel symptomatic agents and would prescribe Lundbeck/Otsuka's selective 5-HT6 receptor antagonist Lu-AE58054 to a median 25 percent of their drug-treated mild to moderate Alzheimer's disease patients,...

2014-04-14 12:32:55

Researchers recruiting patients with mild to moderate Alzheimer's disease to participate in six week study SUN CITY, Ariz., April 14, 2014 /PRNewswire/ -- Banner Sun Health Research Institute is proud to announce it is one of just five facilities in the United States to launch a new clinical trial for patients with mild to moderate Alzheimer's disease (AD). This study, titled "Effect of NeuroAD(TM), Combined TMS Stimulation and Cognitive Training, on the cognitive function of mild to...

2014-04-01 12:33:44

LONDON, April 1, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast - Global Analysis Alzheimer's disease drug market is on the curvature stage. Since 2003, there is not any single "magic bullet" launched in the market to prevent or cure it. However, all current marketed products are going to be generic in the next 3-4 years. There are high unmet medical needs....

2014-03-12 08:27:11

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, March 12, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Johnson & Johnson (NYSE: JNJ), Express Scripts Inc. (NASDAQ: ESRX), Merck & Co. Inc. (NYSE: MRK), and Forest Laboratories Inc. (NYSE: FRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings...

2014-03-11 12:29:05

LONDON, March 11, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Alzheimer's Disease Therapeutics and Diagnostics: World Market 2013-2023 Report DetailsAlzheimer's medicine - your guide to technologies, trends and revenuesWhere's treatment of Alzheimer's disease heading? Visiongain's new report gives you revenue predictions for those drugs and diagnostic tests from 2013, helping you stay ahead.There you find financial data, R&D trends,...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related